Clenbuterol Hydrochloride

Verify with FDA CVM →

103 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
103
Total Reports
13
Deaths Reported
1260.0%
Death Rate

Active Ingredients

Clenbuterol Hydrochloride

Administration Routes

OralUnknownSubcutaneous

Species Affected

Horse 76
Unknown 25
Donkey 1
Human 1

Most Affected Breeds

Unknown 26
Quarter Horse 26
Horse (unknown) 13
Thoroughbred 5
Miniature 4
Crossbred Equine/horse 3
Arab 3
Morgan 3
Horse (other) 3
Tennessee Walking Horse 3

Most Reported Reactions

Lack of efficacy - NOS 18
Death 8
Increased sweating 8
Hyperhidrosis 7
Anorexia 7
Tachycardia 6
Increased respiratory rate 6
Excessive sweating 5
Vials, Damaged 4
Abdominal pain 4
Underfilling, Vials 4
Heart murmur 4

Outcome Breakdown

Recovered/Normal
27 (38.0%)
Outcome Unknown
26 (36.6%)
Died
8 (11.3%)
Euthanized
5 (7.0%)
Ongoing
4 (5.6%)
Recovered with Sequela
1 (1.4%)

Data Summary

Metric Value
Total adverse event reports 103
Reports involving death 13
Case-fatality rate (reported events) 1260.0%
Distinct species in reports 4
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Clenbuterol Hydrochloride Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 103 adverse event reports referencing Clenbuterol Hydrochloride, including 13 reports in which the animal died — a 1260.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Clenbuterol Hydrochloride. Reported administration routes include Oral, Unknown, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Clenbuterol Hydrochloride reports are Horse (76 reports), Unknown (25 reports), Donkey (1 reports), with Horse accounting for the largest share. Within those species, Unknown (26), Quarter Horse (26), Horse (unknown) (13) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Clenbuterol Hydrochloride are Lack of efficacy - NOS (18), Death (8), Increased sweating (8), Hyperhidrosis (7). Of the 71 reports with a coded outcome, Recovered/Normal is the leading category at 38.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Clenbuterol Hydrochloride.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial